COSM$0.2953-4.40%
Cosmos Health Inc.
Sector: Wholesale-Drugs, Proprietaries & Druggists' SundriesIndustry: Medical - PharmaceuticalsCountry: GRExchange: Nasdaq
Mkt Cap:$29.72M
Float & O/S:
Inst Own:
DilutionScan read 23 of Cosmos Health Inc.'s SEC filings and found 9 warrant series, 9 convertibles, 1 ATM program, 6 shelf registrations, 5 S-1 registrations and 6 completed offerings on file for COSM. The latest dilution event on file is an offering on Jun 30, 2026. Analysis updated Sep 28, 2026.
Signal8 Summary
COSM
Going-concern warning, negative cash runway
Snapshot
Cosmos Health is a tiny pharmaceutical firm growing revenue fast but burning cash even faster. FY 2025 revenue hit $65.3M (up 20% YoY), yet the company posted a $19.1M net loss and burned $8.5M in free cash flow.
What's Happening Right Now
- : Cosmos Health reported preliminary record Q2 2026 revenue of $19.4M, up 31.5% year-over-year, and record first-half revenue of $37.3M.
- : The Board of Directors authorized a share repurchase program of up to $5 million, representing nearly half of the company's market capitalization.
- : Cosmos Health secured an additional 180-day extension from Nasdaq to regain compliance with the minimum bid price requirement.
- : The company identified approximately $20 million in non-core assets, including real estate and digital assets, available for monetization to improve liquidity.
- : The company reported Q1 2026 revenue growth but raised substantial doubt about its ability to continue as a going concern due to a working capital deficiency.
